Summit Therapeutics: Remarkable Results in Phase III HARMONI Trial for Lung Cancer
Summit Therapeutics has completed enrollment in the multi-regional Phase III HARMONi trial, evaluating ivonescimab in combination with chemotherapy for...
Jon Napitupulu
ACTICOR Biotech Secures Receivership Extension for Glenzocimab Development
The Paris Commercial Court has granted an extension of receivership proceedings for ACTICOR Biotech, a biopharmaceutical company focused on...
U.S. FDA Approves Opdivo® for Resectable Non-Small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) for treating adults with resectable non-small cell lung...
Humanetics Corp. Wows at 2024 DoD Scientific Meeting: A Testimony to Enduring Innovation
Humanetics Corporation presented updates on the progress of BIO 300, an orally administered drug designed to prevent radiation toxicity...
Allele-Selective Therapies for Rare Genetic Disorders: Regulatory Challenges and Solutions
Recent advances in genetic sequencing have identified an increasing number of rare heterozygous toxic gain-of-function (TGOF) mutations. These mutations...
DeepCure Presents Breakthrough Data: DC-9476 Triumphs over Etanercept in Rheumatoid Arthritis Battle
DeepCure, a biotechnology company, has unveiled promising data on its selective BRD4 (BD2) inhibitor, DC-9476. Preclinical studies indicate its...
Calquence (Acalabrutinib) Receives Priority Review in the US for Untreated Mantle Cell Lymphoma Patients
AstraZeneca‘s CALQUENCE (acalabrutinib) has received Priority Review designation from the FDA for treating untreated adult patients with mantle cell...
Wellvii™ and Dr. Todd McMullen: VitalDetect® for Remote Blood Pressure Patient Monitoring in Rural Areas
Wellvii’s VitalDetect offers a groundbreaking approach to non-invasive blood pressure monitoring. Unlike traditional arm cuffs, the VitalDetect utilizes a...
Unparalleled Launch: VMD Sciences Expands Life-Saving Access Programs
VMD Sciences, a pioneering company in biomedical innovation for pets, has launched Expanded Access Programs (EAPs) for pets and...
Unlock Real Chemistry’s Elevate Partnership for Exceptional Biopharma Commercialization
Real Chemistry and Corval have forged a partnership to provide biopharma companies with an innovative platform for commercialization planning...